AMTX vs LEN · rev $77.2M vs rev $34.19B
Aemetis Inc (AMTX) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Aemetis Inc (AMTX) is a specialty chemicals company listed on US.
LEN (LEN) common stock.
Latest reported AMTX revenue for 2023-12-31 was $77.2M. Net income was -$46.4M. Revenue was up 174.6% from 2022-12-31 to 2023-12-31. AMTX currently screens at market cap $158.3M.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
AMTX currently screens at market cap $158.3M. LEN currently screens at market cap $0.
Not investment advice. Open the AMTX and LEN stock pages for the full models.
Not investment advice.